Medicare Enrolled
Dr. Yu Cheng, M.D.
Neurology · La Mesa, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cheng from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cheng?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cheng
Dr. Yu Cheng is a neurology specialist in La Mesa, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cheng performed 1,825 Medicare services across 758 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cheng received a total of $29,903 from 90 pharmaceutical and/or device companies across 1519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cheng is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in CA
$29,903 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,825
Medicare services
Top 22% in CA for neurology
758
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
607 | $98 | $220 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
415 | $95 | $290 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
286 | $173 | $631 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
167 | $65 | $186 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $143 | $428 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
72 | $47 | $123 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
40 | $107 | $357 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $133 | $362 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
37 | $47 | $148 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
23 | $315 | $813 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $143 | $393 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,903
Total received (2018-2024)
Avg $4,272/year across 7 years
Top 12% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
90
Companies
1,519
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,513 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$390 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,275
2023
$4,434
2022
$4,691
2021
$4,393
2020
$4,144
2019
$2,735
2018
$4,231
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$938
ABBVIE INC.
$565
MDD US Operations, LLC
$340
Neurelis, Inc.
$337
Neurocrine Biosciences, Inc.
$277
Teva Pharmaceuticals USA, Inc.
$236
Lilly USA, LLC
$231
Lundbeck LLC
$212
Biogen, Inc.
$208
Genentech USA, Inc.
$181
Eisai Inc.
$177
Takeda Pharmaceuticals U.S.A., Inc.
$177
SK Life Science, Inc.
$175
ACADIA Pharmaceuticals Inc
$174
Amneal Pharmaceuticals LLC
$145
TG Therapeutics, Inc.
$139
PFIZER INC.
$88
Novartis Pharmaceuticals Corporation
$64
MITSUBISHI TANABE PHARMA AMERICA, INC.
$61
InSightec,Inc
$59
Grifols USA, LLC
$57
ARGENX US, INC.
$52
Sumitomo Pharma America, Inc.
$51
Alnylam Pharmaceuticals Inc.
$50
CATALYST PHARMACEUTICALS, INC.
$50
SCILEX PHARMACEUTICALS INC.
$43
Kyowa Kirin, Inc.
$42
Alexion Pharmaceuticals, Inc.
$32
Vanda Pharmaceuticals Inc.
$30
EMD Serono, Inc.
$28
AstraZeneca Pharmaceuticals LP
$22
Merz Pharmaceuticals, LLC
$20
Celgene Corporation
$15
Top 3 companies account for 34.9% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$2,837
Biogen, Inc.
$1,475
LivaNova USA, Inc.
$1,397
Neurocrine Biosciences, Inc.
$1,284
ABBVIE INC.
$1,206
AbbVie Inc.
$1,071
SK Life Science, Inc.
$1,035
Medtronic USA, Inc.
$1,007
Neurelis, Inc.
$969
Sunovion Pharmaceuticals Inc.
$945
Teva Pharmaceuticals USA, Inc.
$917
Novartis Pharmaceuticals Corporation
$830
Eisai Inc.
$812
Lilly USA, LLC
$806
Lundbeck LLC
$797
Amgen Inc.
$674
ACADIA Pharmaceuticals Inc
$581
GENZYME CORPORATION
$567
Takeda Pharmaceuticals U.S.A., Inc.
$523
MDD US Operations, LLC
$448
AstraZeneca Pharmaceuticals LP
$431
EISAI INC.
$420
Genentech USA, Inc.
$416
Alexion Pharmaceuticals, Inc.
$410
ARGENX US, INC.
$406
GE HEALTHCARE
$388
CSL Behring
$348
Amneal Pharmaceuticals LLC
$338
Alnylam Pharmaceuticals Inc.
$320
Almatica Pharma LLC
$295
Grifols USA, LLC
$292
EMD Serono, Inc.
$282
Janssen Pharmaceuticals, Inc
$266
Horizon Therapeutics plc
$265
Allergan, Inc.
$251
Acorda Therapeutics, Inc
$251
PFIZER INC.
$230
Biohaven Pharmaceutical Holding Company Ltd.
$227
Vanda Pharmaceuticals Inc.
$225
Kyowa Kirin, Inc.
$214
Supernus Pharmaceuticals, Inc.
$178
Adamas Pharmaceuticals, Inc.
$173
Banner Life Sciences, LLC
$170
Chiesi USA, Inc.
$161
ARBOR PHARMACEUTICALS, INC.
$161
Avanir Pharmaceuticals, Inc.
$150
MITSUBISHI TANABE PHARMA AMERICA, INC.
$142
TG Therapeutics, Inc.
$139
Biohaven Pharmaceuticals, Inc.
$130
Celgene Corporation
$111
Sumitomo Pharma America, Inc.
$108
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
CATALYST PHARMACEUTICALS, INC.
$92
Currax Pharmaceuticals LLC
$88
Assertio Therapeutics, Inc.
$84
PORTOLA PHARMACEUTICALS, INC.
$80
Greenwich Biosciences, Inc.
$77
Akcea Therapeutics, Inc.
$72
BAXTER HEALTHCARE
$72
Medtronic, Inc.
$71
Vertical Pharmaceuticals, LLC
$67
GE HealthCare
$65
US WorldMeds, LLC
$64
JAZZ PHARMACEUTICALS INC.
$63
InSightec,Inc
$59
E.R. Squibb & Sons, L.L.C.
$55
Abbott Laboratories
$50
Otsuka America Pharmaceutical, Inc.
$49
SANOFI-AVENTIS U.S. LLC
$47
Catalyst Pharmaceuticals, Inc.
$46
SCILEX PHARMACEUTICALS INC.
$43
Mitsubishi Tanabe Pharma America, Inc.
$42
Novo Nordisk Inc
$42
Medtronic Vascular, Inc.
$41
Avion Pharmaceuticals
$41
Amylyx Pharmaceuticals, Inc.
$38
BANNER LIFE SCIENCES, LLC
$37
IMPEL PHARMACEUTICALS INC.
$25
TG THERAPEUTICS, INC.
$24
Corium, LLC
$23
Promius Pharma LLC
$23
GRT US Holding, Inc.
$21
Philips Electronics North America Corporation
$20
Merz Pharmaceuticals, LLC
$20
Arbor Pharmaceuticals, Inc.
$17
W. L. Gore & Associates, Inc.
$16
AbbVie, Inc.
$15
Boston Scientific Corporation
$13
Strongbridge US INC.
$13
Impax Laboratories, Inc.
$12
Top 3 companies account for 19.1% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BRILINTA · BRIUMVI · Briviact · CAMBIA · CARDIOFORM Septal Occluder · CLEVIPREX · CONTRAVE · CREXONT · Cambia · DUOPA · Dayvigo · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · Exablate · FANAPT · FIRDAPSE · FLOSEAL · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HETLIOZ · HYQVIA · Hetlioz · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KENGREAL · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LEQVIO · LINQ II · Leqembi · MAYZENT · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PRADAXA · PREVELEAK · Ponvory · QULIPTA · Qutenza · RADICAVA · RELEXXII · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Repatha · Reveal LINQ · Rybelsus · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TEGSEDI · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · XCOPRI · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
176
Per 100K population
5.4
County median income
$102,285
Nearest hospital
GROSSMONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cheng is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cheng experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Cheng performed 607 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cheng receive payments from pharmaceutical companies?
Yes. Dr. Cheng received a total of $29,903 from 90 companies across 1,519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cheng's costs compare to other neurologists in La Mesa?
Dr. Cheng's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cheng) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in La Mesa
Browse neurologists in La Mesa ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology